36287949|t|Tardive Oromandibular Dystonia Induced by Trazodone: A Clinical Case and Management from the Perspective of the Dental Specialist.
36287949|a|BACKGROUND: Tardive Oromandibular Dystonia is an iatrogenic drug-induced movement form of extrapyramidal symptoms associated primarily with chronic consumption of dopamine receptor blocking agents. Tardive symptoms attributable to selective serotonin reuptake inhibitors antidepressants are far less prevalent. CLINICAL CASE: The authors will present a clinical case and management, from the dental specialist perspective, of a 55-year-old female patient who developed tardive oromandibular dystonia induced by Trazodone prescribed for sleep insomnia. CONCLUSIONS: Trazodone-induced oromandibular dystonia is extremely rare. Early identification and assessment of tardive symptoms are imperative for successful treatment. Trazodone should be prescribed with caution in patients taking other medications with the potential to cause tardive syndromes.
36287949	0	30	Tardive Oromandibular Dystonia	Disease	MESH:D008538
36287949	42	51	Trazodone	Chemical	MESH:D014196
36287949	143	173	Tardive Oromandibular Dystonia	Disease	MESH:D008538
36287949	204	212	movement	Disease	MESH:D009069
36287949	221	244	extrapyramidal symptoms	Disease	MESH:D001480
36287949	294	327	dopamine receptor blocking agents	Chemical	-
36287949	329	345	Tardive symptoms	Disease	MESH:D012816
36287949	578	585	patient	Species	9606
36287949	600	630	tardive oromandibular dystonia	Disease	MESH:D008538
36287949	642	651	Trazodone	Chemical	MESH:D014196
36287949	667	681	sleep insomnia	Disease	MESH:D007319
36287949	696	705	Trazodone	Chemical	MESH:D014196
36287949	714	736	oromandibular dystonia	Disease	MESH:D008538
36287949	795	811	tardive symptoms	Disease	MESH:D012816
36287949	853	862	Trazodone	Chemical	MESH:D014196
36287949	900	908	patients	Species	9606
36287949	962	979	tardive syndromes	Disease	MESH:D000071057
36287949	Negative_Correlation	MESH:D014196	MESH:D007319
36287949	Positive_Correlation	MESH:D014196	MESH:D008538

